Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05664243
What this trial is testing

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
In8bio Inc. 4
Large-scale testing (Phase 3)Study completedNCT00861614
What this trial is testing

Study of Immunotherapy to Treat Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 988
Testing effectiveness (Phase 2)Looking for participantsNCT03740893
What this trial is testing

PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer

Who this might be right for
Breast NeoplasmTriple Negative Breast Cancer (TNBC)HRD
Institute of Cancer Research, United Kingdom 119
Large-scale testing (Phase 3)Study completedNCT01057810
What this trial is testing

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 837
Testing effectiveness (Phase 2)Study completedNCT02351739
What this trial is testing

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer

Who this might be right for
Metastatic Urothelial Carcinoma
Acerta Pharma BV 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06600841
What this trial is testing

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer (PROC)Immunotherapy
Fujian Cancer Hospital 37
Early research (Phase 1)Active Not RecruitingNCT05806814
What this trial is testing

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
University of Oklahoma 15
Testing effectiveness (Phase 2)Study completedNCT02431559
What this trial is testing

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Ludwig Institute for Cancer Research 53
Large-scale testing (Phase 3)Not Yet RecruitingNCT07653451
What this trial is testing

Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 90
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Looking for participantsNCT07071103
What this trial is testing

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

Who this might be right for
RadiotherapyMetastatic Solid CancersImmune Checkpoint Blockade+3 more
Chuangzhen Chen 48
Testing effectiveness (Phase 2)Looking for participantsNCT07250542
What this trial is testing

A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
baotai Liang 30
Early research (Phase 1)Looking for participantsNCT07641049
What this trial is testing

Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerAdvanced Prostate AdenocarcinomaPSCA-positive Prostate Cancer+1 more
Beijing Biotech 36
Early research (Phase 1)Not Yet RecruitingNCT05662904
What this trial is testing

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
German Cancer Research Center 12
Testing effectiveness (Phase 2)Study completedNCT05068427
What this trial is testing

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Who this might be right for
Non Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 34
Early research (Phase 1)Not Yet RecruitingNCT07756593
What this trial is testing

Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Washington University School of Medicine 30
Not applicableLooking for participantsNCT07066917
What this trial is testing

Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hellenic Cooperative Oncology Group 150
Testing effectiveness (Phase 2)Looking for participantsNCT06551272
What this trial is testing

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Center Eugene Marquis 34
Early research (Phase 1)Looking for participantsNCT05354375
What this trial is testing

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Immunotherapy
The Affiliated Hospital of Xuzhou Medical University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06731153
What this trial is testing

JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC

Who this might be right for
Triple Negative Breast Cancer (TNBC)Metastatic Breast Cancer
Fudan University 40
Next Page